BioSpace News Archive

BioMidwest

Canopy Biosciences Announces Catalog of Genetically Engineered Cell Lines and Lysates

Canopy brings CRISPR technology within the reach of millions of researchers worldwide.

October 1, 2018
·
2 min read
BioMidwest

Abbott′s FreeStyle® Libre 2, with Optional Real-Time Alarms, Secures CE Mark for Use in Europe

New features further enhance Abbott′s market leading sensor-based continuous glucose monitoring technology

October 1, 2018
·
4 min read
Drug Development

Torque Announces the Presentation of Preclinical Data for Deep IL-15 Primed T Cells Demonstrating Superior T Cell Expansion, Persistence, and Safety Compared with Systemically Administered IL-15

Torque announced today preclinical data demonstrating superior T cell expansion, persistence, and safety for the company’s Deep IL-15 Primed T cells compared to systemically administered IL-15.

October 1, 2018
·
4 min read
Policy

Specialty Enzymes & Probiotics Receives Coveted NSF GMP Certification

Company is one of the first enzyme manufacturers to achieve esteemed NSF International Good Manufacturing Practices designation

October 1, 2018
·
2 min read
Business

BioLife Solutions Reports Record Third Quarter 2018 Preliminary Revenue of $5.3 Million, up 79% Year-over-Year

BioLife Solutions, Inc. today reported preliminary revenue for the three months ended September 30, 2018 and provided updated revenue guidance for the full year of 2018.

October 1, 2018
·
4 min read
Business

Boston Scientific Announces Conference Call Discussing Third Quarter 2018 Financial Results

Boston Scientific Corporation will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2018 on Wednesday, October 24, 2018.

October 1, 2018
·
1 min read
Business

Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 24, 2018

Thermo Fisher Scientific Inc., announced that it will release its financial results for the third quarter before the market opens on Wednesday, October 24, 2018, and will hold a conference call on the same day at 8:30 a.m. EDT.

October 1, 2018
·
1 min read
Drug Development

Blueprint Medicines Presents Foundational Preclinical Data Supporting the Development of BLU-782, a Highly Selective ALK2 Inhibitor, for the Treatment of Patients with Fibrodysplasia Ossificans Progressiva

Plan to Initiate Phase 1 Clinical Trial in Healthy Volunteers in First Quarter of 2019

October 1, 2018
·
7 min read
Business

Allergan to Report Third Quarter 2018 Earnings and Host Conference Call and Webcast

Allergan plc today announced that it intends to release third quarter 2018 financial results on Tuesday, October 30, 2018, prior to the open of U.S. financial markets.

October 1, 2018
·
2 min read
Business

Trait Appoints International Marketing Executive, and former Diageo N.A. President & Chief Marketing Officer, Peter McDonough to Board of Directors

Trait Biosciences Inc. announced today that Peter J. McDonough, one of the world’s leading consumer brand and marketing experts, has joined its Board of Directors, effective immediately.

October 1, 2018
·
5 min read